Viewing Study NCT02098395


Ignite Creation Date: 2025-12-24 @ 1:43 PM
Ignite Modification Date: 2026-01-29 @ 6:20 PM
Study NCT ID: NCT02098395
Status: COMPLETED
Last Update Posted: 2017-02-09
First Post: 2014-03-25
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes View
None Diabetes Mellitus, Type 1 View
Keywords: